retatrutide cons Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Pros and Cons of Retatrutide:

The compound is inexpensive enough to study on its own, and the GLOW Blend can be added to a subsequent research phase without discarding prior work

Collectively, the modulation of cellular lipid composition may disrupt ferroptosis

The results of liver histopathology and liver serum biochemistry examined in NAFLD mice show that GA administration prevents hepatic adipose deformation, insulin resistance, and hypercholesterolemia induced by HFD

Additionally, the peptide has been studied in animal models for its ability to stimulate growth hormone release while maintaining relatively selective endocrine effects compared to other secretagogues

DOI: 10.1158/1055-9965.EPI-09-0701

A European cohort from Erasmus MC (Netherlands) showed that overweight, diabetes, hypertension, and dyslipidemia independently increased liver-related events, including HCC, transplantation, and mortality, with multiple comorbidities amplifying risk several-fold across subgroups, including virally suppressed and non-cirrhotic patients (94)